awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36333760-21E61205-D50C-42B8-A1AD-6410D65A1DDE
Q36333760-21E61205-D50C-42B8-A1AD-6410D65A1DDE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36333760-21E61205-D50C-42B8-A1AD-6410D65A1DDE
Jardiance (Empagliflozin), an SGLT2 Inhibitor, Receives FDA Approval for the Treatment of Patients with Type 2 Diabetes
P2860
Q36333760-21E61205-D50C-42B8-A1AD-6410D65A1DDE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36333760-21E61205-D50C-42B8-A1AD-6410D65A1DDE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3361b690651798e4910a8de9e4eccc94e2ee1730
P2860
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.